Serious Event

Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event


Ignite Creation Date: 2025-12-24 @ 11:55 AM
Ignite Modification Date: 2025-12-25 @ 11:54 AM
NCT ID: NCT00969761
Term: Haemothorax
Organ System: Respiratory, thoracic and mediastinal disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA 14.1
Notes: None
Study: NCT00969761
Study Brief: BI 6727 (Volasertib) in Combination With Cisplatin or Carboplatin in Patients With Advanced or Metastatic Solid Tumour
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG000 None 0 3 View
EG001 None 0 3 View
EG002 None 1 12 View
EG003 None 0 6 View
EG004 None 0 3 View
EG005 None 0 3 View
EG006 None 0 3 View
EG007 None 0 6 View
EG008 None 0 13 View
EG009 None 0 3 View
EG010 None 0 3 View
EG011 None 0 3 View